Combination Metformin and Oral Contraception for Polycystic Ovary Syndrome (PCOS)

Stopped early · Phase 4 · Has a placebo group

Conditions studied: Polycystic Ovary Syndrome, PCOS, Insulin Sensitivity

In brief

The purpose of this research study is to determine if adding Metformin, a drug that reduces insulin resistance, to birth control pills will reduce the risk of developing type 2 diabetes, high blood pressure. high lipid levels and heart disease in women with PCOS

Key facts

Study ID

NCT00682890

Run by

Virginia Commonwealth University

People needed

28

Starts

2005-11-01

Expected to finish

2010-01-01

Last updated by the study team

2014-08-20

Who can join

Age: 18 and older, up to 45. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Ages 18-45, , 8 menstrual cycles annually, elevated serum free testosterone, normal thyroid function test and serum prolactin, exclusion of late onset adrenal hyperplasia

You may not qualify if…

• Diabetes mellitus, pulmonary, cardiac, renal, hepatic, cholestatic, neurologic, psychiatric, infectious, malignant diseases,history of breast cancer, history of Deep Vein Thrombosis, pregnancy and lactation.

Where it is running

• General Clinical Research Center — Richmond, Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.